EMEA (Europe, Middle East and Africa) Sustained Release Ocular Drug Delivery Systems Market Report 2017

November 2017 | 118 pages | ID: E420104E082EN
QYResearch

Abstracts

In this report, the EMEA Sustained Release Ocular Drug Delivery Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Sustained Release Ocular Drug Delivery Systems for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Sustained Release Ocular Drug Delivery Systems market competition by top manufacturers/players, with Sustained Release Ocular Drug Delivery Systems sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• pSivida
• Allergan
• Icon Bioscience
• Ocular Therapeutix
• Neurotech Pharmaceuticals
• Santen Pharmaceutical
• Aciont Inc.
• Envisia Therapeutics
• GrayBug
• Innocore Pharmaceuticals
• OHR Pharmaceuticals
• PolyActiva
• TheraKine

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Liposome
• Microcapsules/Nanocapsules
• Microspheres/Nanosptheres
• Implants

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Cataract
• Glaucoma
• Corneal Transplantation
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Sustained Release Ocular Drug Delivery Systems Market Report 2017

1 SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS OVERVIEW

1.1 Product Overview and Scope of Sustained Release Ocular Drug Delivery Systems
1.2 Classification of Sustained Release Ocular Drug Delivery Systems
  1.2.1 EMEA Sustained Release Ocular Drug Delivery Systems Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Sustained Release Ocular Drug Delivery Systems Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Liposome
  1.2.4 Microcapsules/Nanocapsules
  1.2.5 Microspheres/Nanosptheres
  1.2.6 Implants
1.3 EMEA Sustained Release Ocular Drug Delivery Systems Market by Application/End Users
  1.3.1 EMEA Sustained Release Ocular Drug Delivery Systems Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Cataract
  1.3.3 Glaucoma
  1.3.4 Corneal Transplantation
  1.3.5 Others
1.4 EMEA Sustained Release Ocular Drug Delivery Systems Market by Region
  1.4.1 EMEA Sustained Release Ocular Drug Delivery Systems Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Sustained Release Ocular Drug Delivery Systems (2012-2022)
  1.5.1 EMEA Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2022)

2 EMEA SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Sustained Release Ocular Drug Delivery Systems Market Competition by Players/Manufacturers
  2.1.1 EMEA Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Sustained Release Ocular Drug Delivery Systems Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Sustained Release Ocular Drug Delivery Systems Sale Price by Players (2012-2017)
2.2 EMEA Sustained Release Ocular Drug Delivery Systems (Volume and Value) by Type/Product Category
  2.2.1 EMEA Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Sustained Release Ocular Drug Delivery Systems Sale Price by Type (2012-2017)
2.3 EMEA Sustained Release Ocular Drug Delivery Systems (Volume) by Application
2.4 EMEA Sustained Release Ocular Drug Delivery Systems (Volume and Value) by Region
  2.4.1 EMEA Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Sustained Release Ocular Drug Delivery Systems Sales Price by Region (2012-2017)

3 EUROPE SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
  3.1.1 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
3.2 Europe Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type
3.3 Europe Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Application
3.4 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume by Countries (2012-2017)
  3.4.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Countries (2012-2017)
  3.4.3 Germany Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  3.4.4 France Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  3.4.5 UK Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  3.4.6 Russia Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  3.4.7 Italy Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)

4 MIDDLE EAST SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
  4.1.1 Middle East Sustained Release Ocular Drug Delivery Systems Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
4.2 Middle East Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type
4.3 Middle East Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Application
4.4 Middle East Sustained Release Ocular Drug Delivery Systems Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Sustained Release Ocular Drug Delivery Systems Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Sustained Release Ocular Drug Delivery Systems Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  4.4.4 Israel Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  4.4.5 UAE Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  4.4.6 Iran Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)

5 AFRICA SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Sustained Release Ocular Drug Delivery Systems Sales and Value (2012-2017)
  5.1.1 Africa Sustained Release Ocular Drug Delivery Systems Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
5.2 Africa Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type
5.3 Africa Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Application
5.4 Africa Sustained Release Ocular Drug Delivery Systems Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Sustained Release Ocular Drug Delivery Systems Sales Volume by Countries (2012-2017)
  5.4.2 Africa Sustained Release Ocular Drug Delivery Systems Revenue by Countries (2012-2017)
  5.4.3 South Africa Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2012-2017)

6 EMEA SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 pSivida
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergan
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Icon Bioscience
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Ocular Therapeutix
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Neurotech Pharmaceuticals
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Santen Pharmaceutical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Aciont Inc.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Envisia Therapeutics
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 GrayBug
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Innocore Pharmaceuticals
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Sustained Release Ocular Drug Delivery Systems Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 OHR Pharmaceuticals
6.12 PolyActiva
6.13 TheraKine

7 SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MANUFACTURING COST ANALYSIS

7.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA SUSTAINED RELEASE OCULAR DRUG DELIVERY SYSTEMS MARKET FORECAST (2017-2022)

11.1 EMEA Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast (2017-2022)
11.2 EMEA Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Sustained Release Ocular Drug Delivery Systems Sales Forecast by Type (2017-2022)
11.7 EMEA Sustained Release Ocular Drug Delivery Systems Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Sustained Release Ocular Drug Delivery Systems
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (Product Category) in 2016
Figure Liposome Product Picture
Figure Microcapsules/Nanocapsules Product Picture
Figure Microspheres/Nanosptheres Product Picture
Figure Implants Product Picture
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application in 2016
Figure Cataract Examples
Table Key Downstream Customer in Cataract
Figure Glaucoma Examples
Table Key Downstream Customer in Glaucoma
Figure Corneal Transplantation Examples
Table Key Downstream Customer in Corneal Transplantation
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) by Region (2012-2022)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Status and Forecast by Countries
Figure Africa Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Volume and Growth Rate (2012-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales Share by Players (2012-2017)
Figure 2016 Sustained Release Ocular Drug Delivery Systems Sales Share by Players
Figure 2017 Sustained Release Ocular Drug Delivery Systems Sales Share by Players
Figure EMEA Sustained Release Ocular Drug Delivery Systems Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) by Players (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Revenue Share by Players (2012-2017)
Table 2016 EMEA Sustained Release Ocular Drug Delivery Systems Revenue Share by Players
Table 2017 EMEA Sustained Release Ocular Drug Delivery Systems Revenue Share by Players
Table EMEA Sustained Release Ocular Drug Delivery Systems Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2012-2017)
Figure Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2012-2017)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Type in 2016
Table EMEA Sustained Release Ocular Drug Delivery Systems Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2012-2017)
Figure Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2012-2017)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2016
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales Share by Region (2012-2017)
Figure Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Region (2012-2017)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Market Share in 2016
Table EMEA Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Sustained Release Ocular Drug Delivery Systems Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Region (2012-2017)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Revenue Market Share Regions in 2016
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2012-2017)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2012-2017)
Table Europe Sustained Release Ocular Drug Delivery Systems Market Share by Type (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2016
Table Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2012-2017)
Table Europe Sustained Release Ocular Drug Delivery Systems Market Share by Application (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2016
Table Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Countries (2012-2017)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Countries (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Countries (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Countries in 2016
Table Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) by Countries (2012-2017)
Table Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries (2012-2017)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries in 2016
Figure Germany Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2012-2017)
Table Middle East Sustained Release Ocular Drug Delivery Systems Market Share by Type (2012-2017)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Market Share by Type (2012-2017)
Table Middle East Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Applications (2012-2017)
Table Middle East Sustained Release Ocular Drug Delivery Systems Market Share by Applications (2012-2017)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application in 2016
Table Middle East Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Countries in 2016
Table Middle East Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) by Countries (2012-2017)
Table Middle East Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries (2012-2017)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries (2012-2017)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries in 2016
Figure Saudi Arabia Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2012-2017)
Table Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type in 2016
Table Africa Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2012-2017)
Table Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2012-2017)
Table Africa Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Countries (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Countries (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Countries in 2016
Table Africa Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) by Countries (2012-2017)
Table Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries (2012-2017)
Figure Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Countries in 2016
Figure South Africa Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Table pSivida Sustained Release Ocular Drug Delivery Systems Basic Information List
Table pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure pSivida Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure pSivida Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Allergan Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Allergan Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Allergan Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Icon Bioscience Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Aciont Inc. Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table GrayBug Sustained Release Ocular Drug Delivery Systems Basic Information List
Table GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure GrayBug Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure GrayBug Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2012-2017)
Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales Market Share in EMEA (2012-2017)
Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Revenue Market Share in EMEA (2012-2017)
Table OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Basic Information List
Table PolyActiva Sustained Release Ocular Drug Delivery Systems Basic Information List
Table TheraKine Sustained Release Ocular Drug Delivery Systems Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sustained Release Ocular Drug Delivery Systems
Figure Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
Figure Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
Table Raw Materials Sources of Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2016
Table Major Buyers of Sustained Release Ocular Drug Delivery Systems
Table Distributors/Traders List
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Region (2017-2022)
Table EMEA Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Region (2017-2022)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Countries (2017-2022)
Table Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Countries (2017-2022)
Table Africa Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Type (2017-2022)
Table EMEA Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources